Out-of-pocket prescription drug costs for adults with cardiovascular risk factors under Amazon's direct-to-consumer pharmacy service
Study context
- Population
- US adults 18–64 years with CV risk factors or conditions prescribed ≥1 Amazon RxPass formulary medication, 2019 Medical Expenditure Panel Surveyweighted estimate
- Participants
- 25,280,517 adults
- Outcome
- Out-of-pocket savings on generic prescription medications through Amazon RxPass ($5/month subscription)
Main finding
As reported in the abstract
Adults who would achieve out-of-pocket savings with RxPass
Proportion achieving savings
6.4% (1,624,587 [SE ± 68,571])
Average out-of-pocket savings among those achieving savings, per person per year
$140
SE ± $15.8
Total savings
$228,093,570
SE ± $26,117,241
Observational data: associations, not effects.
Further findings
Factors associated with achieving out-of-pocket savings from RxPass (multivariable regression)
| Adjusted OR (95% CI) | ||
|---|---|---|
| Lack of insurance coverage | 3.5 (1.9–6.5) | |
| 0.10.31310Adjusted odds ratio (log scale) |
| Outcome | OR (95% CI) | |
|---|---|---|
| Factors associated with achieving out-of-pocket savings from RxPass (multivariable regression)2-3 RxPass-eligible medicationsvs 1 medication | 5.6 (3.0–10.3) | |
| Factors associated with achieving out-of-pocket savings from RxPass (multivariable regression)4+ RxPass-eligible medicationsvs 1 medication | 21.8 (10.7–44.3) | |
| 0.050.21520Odds ratio (log scale) |
Original publication
Out-of-pocket prescription drug costs for adults with cardiovascular risk factors under Amazon's direct-to-consumer pharmacy service. Am Heart J. Published 15 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →